Niterra (Medical Lake Business Unit)
How Niterra Unlocked a $160M Market by Putting Patients First
ENGAGEMENTVenture Building, Market Research, Product Design, and Development
sECTORHealthcare / Respiratory Care / Medical Devices
OVERVIEWNiterra, a global leader in respiratory health, partnered with Boardroom Labs to reimagine portable oxygen therapy for people with COPD. The challenge wasn’t just technical, existing devices were bulky, stigmatizing, and poorly aligned with patients’ lifestyles, leading to underuse. Together, we designed Moda Smart Oxygen Therapy, a validated platform combining next-generation hardware, digital health tools, and AI-enabled preventative care, unlocking new revenue for Niterra while transforming patient experience and care delivery.
validated venture concepts developed
3
patient interviews & 32 clinician interviews conducted
57
end users engaged in quantitative validation
574
integrated POC platform (Moda Sense) prototyped
1
addressable market identified with clear go-to-market strategy
$160M
The ProblemNiterra needed to compete in a market dominated by bulky, stigmatizing oxygen devices that patients avoided using and clinicians couldn’t effectively monitor, leading to poor adherence, preventable exacerbations, and rising healthcare costs.
What We Built-
Moda Smart Oxygen Therapy was designed as an integrated ecosystem — combining a discreet, next-generation portable oxygen concentrator with embedded health sensors, a patient mobile app, and a remote patient monitoring platform for clinicians.
-
Moda Sense delivers real-time tracking of SpO₂, respiratory rate, heart rate, and activity in a device that is significantly smaller and quieter than leading competitors — reframing oxygen therapy from a stigmatizing medical device into a lifestyle-enabling solution.
-
A clear pathway was established from Moda Sense to Moda AI, introducing AI-driven exacerbation prediction and personalized interventions — positioning Niterra as a leader in preventative, long-term respiratory care.
OutcomesModa Smart Oxygen Therapy emerged as a market-validated venture with a clear path to scale. The solution is positioned to capture a $160M market opportunity, achieve profitability by FY128, and launch an AI-enabled next generation platform by FY130. Prototypes demonstrated feasibility for real-time patient monitoring, while leadership advanced Moda as a priority Key Opportunity Initiative.
I am excited by the great potential of the technology in development to change lives and reduce the stigma associated with respiratory illness.”
Unnamed, Pulmonologist
